STOCK TITAN

Mei Pharma Inc (MEIP) Net Income by Year

MEIP

Mei Pharma Inc reported a net loss of $15.9M in fiscal year 2025. This represents a decrease of 189.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Mei Pharma Inc has filed alongside them.

FY2025 annual
Net Income -$15.9M
YoY -189.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MEIP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Net Income-$15.9M-189.7%$17.8M+155.6%-$32.0M+40.7%-$54.0M-31.7%-$41.0M+13.1%-$47.2M-180.5%-$16.8M+58.0%-$40.1M-1600.7%$2.7M+112.8%-$20.9M+36.2%-$32.7M-20.4%-$27.1M-142.7%-$11.2M-48.7%-$7.5M-10.9%-$6.8M

MEIP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-KQ2'2610-QQ1'2610-KQ4'2510-KQ3'25Q2'25Q1'25Q4'2410-KQ3'24Q2'24Q1'24Q4'23
Net Income-$23.7M-820.9%-$30.8M-1050.5%-$3.6M+54.6%N/A-$2.6M+71.8%-$2.7M+75.8%-$8.0M-114.2%N/A-$9.1M+40.9%-$11.1M-207.9%$56.4M+439.1%-$10.2M+34.7%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Mei Pharma Inc financials

Frequently Asked Questions

What was Mei Pharma Inc's net income in fiscal year 2025?

Mei Pharma Inc reported a net loss of $15.9M in fiscal year 2025.

How fast is Mei Pharma Inc's net income growing?

Mei Pharma Inc (MEIP) net income fell by 189.7% year over year, from $17.8M to -$15.9M in fiscal year 2025.

How has Mei Pharma Inc's net income changed over the years?

Across the 15 fiscal years this page covers, Mei Pharma Inc (MEIP) net income went from -$6.8M in fiscal year 2011 to -$15.9M in fiscal year 2025.

Mei Pharma Inc (MEIP) reported -$23.7M in net income in Q3 2026. This represents a decrease of 820.9% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Mei Pharma Inc (MEIP) reported on that line in every period on record.